Natco Pharma Ltd.

NSE: NATCOPHARM | BSE: 524816 | ISIN: INE987B01026 | Industry: Pharmaceuticals
| Strong Performer, Under Radar
857.8000 -6.70 (-0.78%)
NSE Sep 23, 2025 10:17 AM
Volume: 84,113
 

logo
Natco Pharma Ltd.
13 Aug 2024
857.80
-0.78%
ICICI Securities Limited
Natco’s Q1FY25 beat was driven by higher sales of gRevlimid while its subsidiaries in Brazil and Canada (INR 1.8bn of sales) also did well.
Number of MF schemes decreased from 54 to 47 in Jun 2025 qtr
More from Natco Pharma Ltd.
Recommended